
TY  - JOUR
TI  - Abstracts
JO  - Research and Practice in Thrombosis and Haemostasis
JA  - Res Pract Thromb Haemost
VL  - 1
IS  - S1
SN  - 2475-0328
UR  - https://doi.org/10.1002/rth2.12012
DO  - doi:10.1002/rth2.12012
SP  - 1
EP  - 1451
PY  - 2017
ER  - 

TY  - JOUR
TI  - WORLD TRANSPLANT CONGRESS 2006 ORAL ABSTRACTS
JO  - American Journal of Transplantation
VL  - 6
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2006.01446.x
DO  - doi:10.1111/j.1600-6143.2006.01446.x
SP  - 65
EP  - 472
PY  - 2006
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 41
IS  - S1
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-018-0233-9
DO  - doi:10.1007/s10545-018-0233-9
SP  - 37
EP  - 219
PY  - 2018
ER  - 

TY  - JOUR
TI  - Apheresis in Critical Care
JO  - Therapeutic Apheresis and Dialysis
VL  - 9
IS  - 3
SN  - 1744-9979
UR  - https://doi.org/10.1111/j.1774-9987.2005.00272.x
DO  - doi:10.1111/j.1774-9987.2005.00272.x
SP  - A3
EP  - A34
PY  - 2005
ER  - 

TY  - JOUR
AU  - Douros, A.
AU  - Bronder, E.
AU  - Andersohn, F.
AU  - Klimpel, A.
AU  - Thomae, M.
AU  - Ockenga, J.
AU  - Kreutz, R.
AU  - Garbe, E.
TI  - Drug-induced acute pancreatitis: results from the hospital-based Berlin case–control surveillance study of 102 cases
JO  - Alimentary Pharmacology & Therapeutics
JA  - Aliment Pharmacol Ther
VL  - 38
IS  - 7
SN  - 0269-2813
UR  - https://doi.org/10.1111/apt.12461
DO  - doi:10.1111/apt.12461
SP  - 825
EP  - 834
PY  - 2013
AB  - Summary Background Drug toxicity is a well-known cause of acute pancreatitis (AP). Although many drugs have been associated with AP, the magnitude of the risk of most of them remains largely unknown. Aim To determine the pancreatotoxic risk of a wide range of drugs. Methods The hospital-based Berlin case?control surveillance study, including all 51 Berlin hospitals in a hospital network, ascertained 102 cases with idiopathic AP (IAP) and 750 controls between 2002 and 2011. Patients with IAP were thoroughly validated using anamnestic, clinical or laboratory data. Drug exposure was obtained in a face-to-face interview. Possible drug aetiology was assessed in individual patients through a standardised causality assessment applying the criteria of the World Health Organization. Drug risks were further quantified [odds ratios (OR) with 95% confidence intervals (CI)] in a case?control design with unconditional logistic regression analysis. Results The pancreatotoxic risk of several drugs, including azathioprine (OR 5.1; 95% CI 1.9?13.5), fenofibrate (OR 12.2; 95% CI 2.3?69.1), mesalazine (OR 3.3; 95% CI 1.1?9.5) or angiotensin-converting enzyme inhibitors, was corroborated by case?control analysis and causality assessment. Causality assessment suggested a pancreatotoxic potential, among others, for mercaptopurine or the seldom reported leflunomide, and alluded to a novel risk for tocilizumab. Case?control analysis showed an increased risk for two phytotherapeutics: harpagophytum and valerian radix. Conclusions Our study quantified the pancreatotoxic risk of different drugs and phytotherapeutics. The findings corroborate previous results from the literature but also indicate risks for substances not previously reported, highlighting the need for further controlled studies on pancreatic toxicity.
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 49
IS  - S38
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.23108
DO  - doi:10.1002/ppul.23108
SP  - S216
EP  - S456
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Hepatology
JA  - Hepatology
VL  - 54
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.24666
DO  - doi:10.1002/hep.24666
SP  - 360A
EP  - 1455A
PY  - 2011
ER  - 

TY  - JOUR
TI  - Program & Abstracts
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 17
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650170102
DO  - doi:10.1002/jbmr.5650170102
SP  - S1
EP  - S502
PY  - 2002
ER  - 

AU  - Kapoor, Rakesh
AU  - Nair, Harikumar
C7  - pp. 1-45
TI  - Gamma Linolenic Acid: Sources and Functions
SN  - 9780471384601
UR  - https://doi.org/10.1002/047167849X.bio026.pub2
DO  - doi:10.1002/047167849X.bio026.pub2
SP  - 1-45
KW  - GLA (gamma linolenic acid)
KW  - sources
KW  - metabolism
KW  - clinical trials
KW  - anti-inflammatory
KW  - cancer
KW  - arthritis
KW  - diabetes
KW  - essential fatty acid
KW  - borage
KW  - evening primrose
KW  - structured lipids
KW  - hemp
KW  - black currant
PY  - 2002
AB  - Abstract Gamma-linolenic acid (GLA, cis 6, cis 9, cis 12-octadecatrienoic acid) is a conditionally essential fatty acid of the n-6 family. It is produced in the mammalian body from enzymatic desaturation of linoleic acid, an essential fatty acid that must be supplied by the diet. It is widely distributed in plant kingdom in trace amounts, and is not present in major commercial vegetable seed oils. It is present in seeds of many species belonging to families Aceraceae, Boraginaceae, Cannabinaceae, Liliaceae, Onagraceae, Ranunculaceae, Saxifragaceae, and Scrophulariaceae. A very limited number of plant sources have been commercialized in last 30 years as a source of GLA, mainly in the health food industry and to a limited extent in pharmaceutical, pet food, and cosmetic industries. These include oils of borage, black currant, evening primrose, and recently hemp. The total market for GLA-containing oils is about $60?$70 million per year. Research on GLA in last three decades has focused on the physiological and pharmacological effects, including its effects on second messenger system in the body. On the production side, research focus is on identification of new sources and yield optimization. This article reviews the current state of knowledge about sources, and nutritional and health benefits of GLA and attempts to identify areas for future research that will help develop markets for GLA.
ER  - 

TY  - JOUR
TI  - SUBJECT INDEX
JO  - Annals of the New York Academy of Sciences
VL  - 566
IS  - 1
SN  - 9780471384601
UR  - https://doi.org/10.1111/j.1749-6632.1989.tb14662.x
DO  - doi:10.1111/j.1749-6632.1989.tb14662.x
SP  - 169
EP  - 495
PY  - 1989
ER  - 

TY  - JOUR
TI  - NAASO Poster Presentations
JO  - Obesity Research
VL  - 3
IS  - S3
SN  - 9780471384601
UR  - https://doi.org/10.1002/j.1550-8528.1995.tb00206.x
DO  - doi:10.1002/j.1550-8528.1995.tb00206.x
SP  - 386S
EP  - 414S
PY  - 1995
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 50
IS  - s2
SN  - 9780471384601
UR  - https://doi.org/10.1111/j.1537-2995.2010.02833_1.x
DO  - doi:10.1111/j.1537-2995.2010.02833_1.x
SP  - 1A
EP  - 231A
PY  - 2010
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 21st Annual ACVIM Forum Charlotte, NC, June 4–7, 2003
JO  - Journal of Veterinary Internal Medicine
VL  - 17
IS  - 3
SN  - 9780471384601
UR  - https://doi.org/10.1111/j.1939-1676.2003.tb02465.x
DO  - doi:10.1111/j.1939-1676.2003.tb02465.x
SP  - 369
EP  - 460
PY  - 2003
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 2011 ACVIM Forum Denver, Colorado, June 15–18, 2011
JO  - Journal of Veterinary Internal Medicine
VL  - 25
IS  - 3
SN  - 9780471384601
UR  - https://doi.org/10.1111/j.1939-1676.2011.0726.x
DO  - doi:10.1111/j.1939-1676.2011.0726.x
SP  - 632
EP  - 767
PY  - 2011
ER  - 

TY  - JOUR
TI  - Research Communications of the 29th ECVIM-CA Congress
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 34
IS  - 1
SN  - 9780471384601
UR  - https://doi.org/10.1111/jvim.15658
DO  - doi:10.1111/jvim.15658
SP  - 339
EP  - 445
PY  - 2020
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 2010 ACVIM Forum
JO  - Journal of Veterinary Internal Medicine
VL  - 24
IS  - 3
SN  - 9780471384601
UR  - https://doi.org/10.1111/j.1939-1676.2010.0521.x
DO  - doi:10.1111/j.1939-1676.2010.0521.x
SP  - 660
EP  - 795
PY  - 2010
ER  - 

TY  - JOUR
TI  - 24th Clinical Congress Abstracts
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 24
IS  - 1
SN  - 9780471384601
UR  - https://doi.org/10.1177/014860710002400111
DO  - doi:10.1177/014860710002400111
SP  - S1
EP  - S30
PY  - 2000
ER  - 

TY  - JOUR
TI  - POSTERS
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 19
IS  - s2
SN  - 9780471384601
UR  - https://doi.org/10.1111/j.1468-3083.2005.01311.x
DO  - doi:10.1111/j.1468-3083.2005.01311.x
SP  - 1
EP  - 411
PY  - 2005
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 26th Annual ACVIM Forum San Antonio, TX, June 4 – June 7, 2008
JO  - Journal of Veterinary Internal Medicine
VL  - 22
IS  - 3
SN  - 9780471384601
UR  - https://doi.org/10.1111/j.1939-1676.2008.0103.x
DO  - doi:10.1111/j.1939-1676.2008.0103.x
SP  - 687
EP  - 824
PY  - 2008
ER  - 

TY  - JOUR
TI  - Citations from World Literature
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 3
IS  - 5
SN  - 9780471384601
UR  - https://doi.org/10.1177/014860717900300519
DO  - doi:10.1177/014860717900300519
SP  - 393
EP  - 406
PY  - 1979
ER  - 
